HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Chronological study of signs of myoclonic encephalopathy in hemodialysis patients (author's transl)].

Abstract
Twelve patients with chronic renal failure, on maintenance hemodialysis have a stereotyped illness. The dialysate was made up from a high level aluminium tap water. After having been on haemodialysis for 10 to 12 months, they suffer from more and more acute osteodystrophic, osteomalacic symptoms. Then, distinctive EEG abnormalities appear. These first symptoms allow an early diagnosis of the progressive dialytic encephalopathy. The neurological symptoms appear some months later. Eight patients died from this encephalopathy. Four patients are still alive and are, from at least two years, on maintenance haemodialysis with a free aluminium water. In these 4 cases, the evolution of the disease is good: osteomalacic symptoms disappear in a year; the neurological symptoms are still present though transient. EEG abnormalities remain and blood aluminium level is about 100 micrograms/L. These cases show, once more, the significant role of aluminium as an aetiological factor in "progressive dialysis encephalopathy".
AuthorsM F Vecchierini-Blineau, H E Thebaud, L Dupouet, D Brochard, P Coville, J R Feve, P Guiheneuc
JournalLa semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris (Sem Hop) 1981 Nov 18-25 Vol. 57 Issue 43-44 Pg. 1823-30 France
Vernacular TitleEtude chronologique des signes de l'encéphalopathie myoclonique des hémodialysés. Signes précurseurs et évolution chez douze patients.
PMID6274030 (Publication Type: Journal Article)
Chemical References
  • Aluminum
Topics
  • Adult
  • Aged
  • Aluminum (adverse effects)
  • Brain Diseases (physiopathology)
  • Chronic Kidney Disease-Mineral and Bone Disorder (etiology)
  • Electroencephalography
  • Female
  • Humans
  • Kidney Failure, Chronic (complications)
  • Male
  • Middle Aged
  • Myoclonus (etiology)
  • Renal Dialysis (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: